companiesCompany
Serova
Serova is an early-stage company building a personalised cancer vaccine platform that redesigns the vaccine as the tumour evolves.
Serova's platform uses longitudinal, multi-site tumour data to select tumour-driving mutations and design patient-specific vaccines reflecting disease state at the time of dosing. Pre-clinical; limited public disclosure beyond company profiles.
Pages like this
not linked directly; found by shared links- PersonKellie N. Smith
- PersonMalachi Griffith
- PersonNina Bhardwaj
- IdeaVaccinate against the resistance mutation before it takes over
- IdeaWhat makes a neoantigen actually immunogenic?
- IdeaA frameshift neoantigen vaccine for Lynch syndrome carriers as the first preventive cancer vaccine approval
- IdeaVaccines aimed only at mutations shared by every tumour cell
- InstitutionUniversity Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz